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Introduction
Although everyone is affected by the COVID-19 pandemic, the impact is not shared equally. This
document, which draws on a recent WHO global review of national deployment and vaccination plans
and experience from their implementation and the vaccine rollout worldwide plus literature reviews and
existing WHO guidance and tools, provides key principles and policy consideration on equitable
prioritization and access to COVID-19 vaccines for refugees and migrants.
The document provides information on key challenges and barriers to accessing vaccination services
and key considerations in addressing them, as well as good practices. It highlights principles such as
global equity for vaccine distribution, national equity and equal respect. It also emphasizes the
importance of community engagement and communication to build trust and counter misinformation,
fake news and misconceptions, as well as the importance of developing innovative approaches for
vaccine delivery. The document is derived from rights and policy and practices and does not offer
evidence-based recommendations.

Background
The COVID-19 pandemic has exposed vulnerabilities and exacerbated existing inequalities within and
between low- and high-income countries. These inequalities have had the biggest impact on the poorest
and most vulnerable people, which may include refugees and migrants (particularly those in irregular
situations). These groups often have vulnerabilities that are heightened by this pandemic (1).
Social, political and economic exclusion can result in poverty, homelessness and exploitation, which
can create a higher risk of infection with SARS-CoV-2, the virus that causes COVID-19. Refugees and
migrants may have to live in close quarters or work in conditions with inadequate protection (such as in
overcrowded informal settlements, workers' dormitories, reception and detention centres or insecure
housing arrangements) (2–5), with limited ability to physically distance or self-isolate (6,7). Many
refugees and migrants work in essential sectors with more exposure to the virus and, consequently, are
more vulnerable to infection (8). They may also be more vulnerable because of being outside the
dominant population group through factors such as ethnicity, culture, language or race. They may
experience poor access to quality health care or have suboptimal health-seeking behaviours, distrust of
governments or fear of detention and deportation if seeking health care.
In these contexts, refugees and migrants are more likely to experience a higher burden of COVID-19
infection and be disproportionately represented in cases, hospitalizations and deaths (8). They may also
have a high prevalence of underlying health conditions that increase their risk of severe COVID-19 (9).
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Studies in several member countries of the Organisation for Economic Co-operation and Development
found an infection risk in these groups that was at least twice as high as that for native-born individuals,
with a disproportionately negative toll on refugees and migrants (both regular and irregular) in most
countries for which data are currently available (8,10).
Hence, it is vital to ensure equitable prioritization and access to health care and COVID-19 vaccines for
all groups including refugees and migrants. While States bear the primary responsibility for protecting
and promoting the well-being and human rights of those living within their borders, the global
community also has an obligation to address the human rights claim to vaccines for all those living in
countries who cannot, without assistance, meet their needs. Such actions include reducing the obstacles
to obtaining vaccines that confront countries with fewer resources and less geopolitical power.
Transmission of COVID-19 knows no borders, and as long as there is active transmission anywhere
there will be a risk of transmission everywhere.
The COVID-19 Strategic Preparedness and Response Plan and the Global Humanitarian Response Plan
emphasize the need to protect the vulnerable, including those in low-resource, hard-to-reach and
humanitarian settings (11,12). United Nations resolution 2565 (2021) calls for strengthened
international cooperation to facilitate equitable and affordable access to COVID-19 vaccines in armed
conflict and post-conflict situations and during complex humanitarian emergencies (13).
This document builds on existing COVID-19 immunization guidance documents endorsed by the WHO
Strategic Advisory Group of Experts on Immunization (SAGE) (14,15); the WHO guidance on
developing a national deployment vaccination plan (NDVP) (16); WHO plans to promote the health of
refugees and migrants (17,18); and the Global Immunization Agenda 2030 (19). It also draws on
evidence and experiences from COVID-19 vaccination programmes in refugee and migrant populations
from January to June 2021.
The document targets national authorities, governmental and nongovernmental organizations, health
cluster teams, WHO country offices and United Nations country teams that are responsible for
managing and supporting deployment, implementation and monitoring of COVID-19 vaccines in
refugees and migrants; and partners who provide support.

Methods
The document was developed by the WHO Health and Migration Programme in collaboration with the
Departments of Immunization, Vaccines and Biologicals and Health Emergency Interventions and
partners. The WHO secretariat reviewed the available NDVPs submitted to the COVAX Facility on the
inclusion of refugees and migrants in the COVID-19 vaccination rollout at the country level, and
literature related to COVID-19 vaccination in refugees and migrants. This document is also informed by
experiences from countries on the implementation of COVID-19 vaccination.

Provision of COVID-19 vaccine for refugees and migrants
Principles
Inclusive vaccine plans and strategies are essential to reduce disease and death burdens of COVID-19.
Guiding principles are equitable access to vaccines and that certain target groups at increased risk from
COVID-19 should benefit from early vaccination during the period of vaccine supply constraints. The
WHO SAGE Values Framework for the Allocation and Prioritization of COVID-19 Vaccination (14)
provides six core principles that should guide vaccine distribution: human well-being, global equity,
reciprocity, equal respect, national equity and legitimacy.
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Prioritization of target populations
The WHO SAGE Roadmap for Prioritizing Uses of COVID-19 Vaccines (15) recommends that vaccine
prioritization within countries under the NVDP must consider the vulnerabilities, risks and needs of
groups including refugees and migrant populations who – because of underlying societal, geographical
or biomedical factors – are at significantly higher risk of severe disease and death from COVID-19.
Depending on country context, these groups include disadvantaged or persecuted ethnic, racial, gender
and religious groups and sexual minorities; people living with disabilities; people living in extreme
poverty; the homeless and those living in informal settlements or urban slums; low-income migrant
workers; refugees, asylum-seekers and internally displaced people (IDPs), including vulnerable
migrants in irregular situations; nomadic populations; populations in conflict settings or those affected
by humanitarian emergencies; and hard-to-reach population groups such as those in rural and remote
areas (15).

COVAX and the Humanitarian Buffer
The Gavi COVAX Facility forms a key part of the Access to COVID-19 Tools (ACT) Accelerator to
promote global collaboration for accelerating development, production and equitable access to
diagnostics, therapeutics and vaccines for COVID-19 (20–22). The goal is to deliver 2 billion doses of
safe, effective vaccines to all participating countries by the end of 2021, including to the 92 low- and
middle-incomes countries and territories (LMICs) eligible for the COVAX Advance Market
Commitment (23).
In the first phase, the goal is to provide vaccine for approximately 20% of each country's population,
focusing on health workers and the groups at highest risk of severe disease or death. Further doses will
be made available based on availability, financing, country demand, capacity, vulnerability and
potential threat of outbreaks.
The COVAX Humanitarian Buffer has been established, as part of the COVAX Facility, as a measure
of last resort for populations of concern 1 when other avenues are not available or there are situations not
foreseen during the planning and implementation of NDVPs. The Humanitarian Buffer is global in
scope and is operated as a demand-driven mechanism, with up to 5% of vaccine doses procured through
the COVAX Facility available to cover high-risk populations in humanitarian settings. All COVAX
Facility participants, both self-financing and Advance Market Commitment economies and
humanitarian agencies, including the United Nations and civil society organizations, will be eligible to
apply for doses through the Humanitarian Buffer mechanism (24).

Experience of vaccine rollout and policy response to COVID-19
vaccination in refugees and migrants
Global vaccine equity
As of 30 August 2021, 57.30% of the populations of high-income countries had been vaccinated
compared with 2.14% of those in low-income countries (25). To achieve vaccine equity, low-income
countries would need to increase their health-care spending by an estimated and hard-to-achieve 56.6%,
on average, to cover the costs of vaccinating 70% of their populations (26). For high-income countries,
the estimated increase is only 0.8%. The lack of vaccine supplies and financial implications for
increasing them have significant impacts on the rollout of COVID-19 vaccine in refugees and asylum
seekers since 86% of them live in developing countries (27). Many of these countries also host high
number of migrants.

1

Populations of concern in humanitarian settings may include refugees, asylum seekers, stateless people, IDPs, minorities,
populations in conflict settings or those affected by humanitarian emergencies and vulnerable migrants irrespective of their
legal status.
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Inclusion in NDVPs and vaccine rollouts
From February to March 2021, WHO conducted a review of 104 NDVPs submitted to the COVAX
Facility, of which 86 were Advanced Market Commitment (and 16 are self-financing countries and
economies). The results indicate that the majority of these NDVPs did not explicitly include migrants
(72%). Just over half explicitly included refugees and asylum seekers (53% of 64 countries that have
more than 500 refugees). Only 17% of 104 NDVPs explicitly included migrants in irregular situations.
Global efforts for the inclusion of all populations of refugees and migrants in NDVPs and vaccine
programme implementation have intensified (28–30), and several countries have responded to calls for
vaccine equity by revising and expanding their NDVPs (31). However, international organizations
reported that coverage for these populations in the NDVPs and their implementation are far from
universal. Refugees and asylum seekers have begun to receive vaccinations in 101 of the 162 countries
that the United Nations High Commissioner for Refugees has been monitoring (31). The International
Organization for Migration reported in May 2021 that only regular migrants (those who entered a
country lawfully and remain in the country in accordance with their admission criteria) were included in
vaccination campaigns, while migrants in irregular situations in many countries were not (32).

Barriers to accessing vaccination services and international travel
Some refugees and migrants (particularly migrants in irregular situations) may face multiple barriers to
vaccination and health systems access that are relevant to the implementation of COVID-19 vaccine
programmes in spite of increasing inclusion of these populations at policy level. These barriers include
limited vaccine supply; lack of confidence in vaccine benefits and safety; social influence and norms;
lack of trust and practical information about how to obtain vaccines; outreach and language barriers;
lack of documentation and complex registration processes, such as via the Internet; and fear of arrest,
detention or deportation (33,34). In several countries, operational, administrative and financial barriers
(such as identification documents and residence permits) may hamper access to vaccines by migrants
(35). Restrictions on international travel may also have a particularly severe impact for these groups as
they cannot travel to and from their country of work or origin.

Stigma, exclusion and mistrust, resulting in low vaccine uptake and hesitancy
Some refugees and migrants have had lower levels of routine vaccine uptake and have more distrustful
attitudes towards vaccination compared with the general population (7,36–38). There is evidence that
these populations may be susceptible to vaccine hesitancy (39,40), which can be addressed with clear,
accessible and tailored information campaigns (41). Stigma, discrimination and exclusion, and lack of
access to quality health care, represent additional barriers (40), and these factors can exacerbate any
mistrust in government and create alienation from public health services.
For example, a recent study in the United Kingdom reported that 72% of the refugees and migrants
contacted felt hesitant about accepting a COVID-19 vaccine. Reasons given included concerns over
vaccine content, side effects, lack of information or low perceived need. This suggests that hesitancy
could be easily addressed with clear, accessible and tailored information campaigns (41).

Lack of financial means and information
The WHO Apart Together study found that not all migrants interviewed would seek medical care in
case of suspected COVID-19-infection for a number of reasons, including a lack of financial means,
fear of deportation, lack of availability of health-care providers or lack of entitlement to health care.
Better programme design will be required to meet their specific needs (42).
A survey in June 2021 of 52 national Red Cross and Red Crescent societies found that 90% reported
lack of information or awareness on where and how to access COVID-19 vaccines as a key barrier for
migrants, with 67% identifying language barriers (34).
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Fears regarding cost, safety and deportation or detention
Other barriers identified include fears over cost of the vaccine, fears of data sharing between the health
service and immigration enforcement, lack of information on where to get vaccine and other issues
relating to convenience (41). Lack of trust in authorities was a key theme, including concerns around
immigration checks or other unwanted questions from health-care providers when people presented for
a COVID-19 vaccine (41).
A study among migrant workers in Shanghai found concerns about vaccine safety and effectiveness and
a lack of awareness about the vaccine. While over 90% considered COVID-19 vaccination as important,
only 75% agreed that the vaccine is safe and 78% that it was effective (43). In Lebanon, an ongoing
study about vaccine hesitancy among Syrian refugees has shown that the majority of the sample (66%)
reported an intention to receive a COVID-19 vaccine if it is safe and free (44,45). In Qatar, a study
found that the residency status of all migrant workers was tied to their employment contracts, so they
were more likely to accept the policy of the Government or their employer on COVID-19 vaccinations
(46).

Vaccination certificate and international travel
As countries gradually resume or readjust non-essential international travel and introduce risk
mitigation measures with the help of digital health certificates, there are growing concerns that these
developments may exclude or discriminate against vulnerable populations, including refugees and
migrants, who may not be able to access or receive a COVID-19 vaccine or have documented proof of
recovery from previous infection (35).

Outreach and other strategies
Several countries are preparing for accelerating and expanding vaccine programme implementation and
planning to put in place effective communication campaigns, open more mass vaccination centres and
pilot mass vaccination procedures. Outreach measures include pop-up clinics for communities less
likely to engage with static sites (such as at homeless shelters); bespoke or targeted clinics at settings of
convenience (such as faith settings, community venues, walk-in centres and drive-through facilities);
and use of venues such as sexual health clinics (47). Many cities have also provided efficient outreach
and low-barrier access through mobile outreach sites (so-called vaccination buses) accessible for all at
marketplaces or in areas where many migrants or homeless people live.
Examples of country practices
Across all WHO regions, several good practices have emerged for ensuring the inclusion of refugees
and migrants in vaccination and health care for COVID-19. In the WHO Region of the Americas, most
countries have included refugees and other displaced people in their vaccination programme
implementation. For example, Colombia has provided 10-year temporary protection status to
Venezuelan migrants, which would allow them to register for vaccination (48). In the United States of
America, no identification is required to receive a vaccine (49,50). Several high-income countries in the
WHO European Region have announced that they will vaccinate all people in their territory. Some
countries such as the Republic of Moldova and Serbia have delivered vaccines to asylum centres. Most
countries in the WHO African and the Eastern Mediterranean Regions have stated that they will include
refugees in their vaccination programmes. In Jordan, by late May, 30% of refugees eligible for the
COVID-19 vaccine had received at least their first dose (51). Cameroon and Senegal have allowed
refugees to register in designated centres near their communities (31). In the South East Asia and
Western Pacific Regions, countries including Australia, Bangladesh, Malaysia, Maldives and Thailand
have included refugees and migrants in their NDVPs.
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Principles and key considerations
Ensure universal and equal access to the COVID-19 vaccine for refugees and
migrants regardless of migration status, with access the same as for nationals
•

•

•

•

•

The principle of global equity is to ensure that all countries have fair access to vaccines and to
ensure that vaccine allocation takes into account the special epidemic risks and needs of all
countries, particularly for LMICs. Although countries bear the primary responsibility for
protecting and promoting the well-being and human rights of those living within their borders, it
is important that this national concern does not absolve States of obligations to people in other
countries (16).
Governments should ensure that all refugees and migrants are included in their COVID-19
vaccination and other health services programmes (52). Special arrangements should be made
for those excluded from health systems, building on existing immunization programmes. This
will require a major targeted effort to advocate for and facilitate access to vaccines for these
populations alongside host populations. Dedicated financial support/vaccine donations for
LMICs by donor countries and international governmental and nongovernmental organizations
will also be required.
In countries where NDVPs are being developed or updated (16,53), it is critical for policymakers and partners involving in the NDVP development to review the required national and
local capacity for implementation, readiness, legal frameworks and regulatory requirements for
vaccinating all refugees and migrants regardless of status, including proof of identity
requirements (54,55).
Mechanisms should be established in collaboration with governmental and civil society
organizations to monitor COVID-19 vaccination uptake in these populations to ensure that these
policies are put into practice (56,57). It is of paramount importance to obtain accurate
population estimates to facilitate the allocation of resources, vaccine procurement, deployment
planning and to help to estimate vaccination coverage and needs in specific settings (58).
In line with SAGE recommendations, prioritization of target populations should be done
through transparent protocols and procedures that respect human rights for all populations and
with the same vaccine quality and efficacy/effectiveness standards applied. Throughout the
deployment of COVID-19 vaccines, a gender and human right perspective needs to be
incorporated into all activities to ensure maximum success (16).

Addressing barriers that prevent refugees and migrants from accessing
COVID-19 vaccination services and international travel
•

•

•

Health systems must be culturally and linguistically sensitive to the needs of refugees and
migrants and the circumstances that may increase their health risks and generate barriers in
accessing treatment and care (59). Health-care and administrative staff should be adequately
trained in responding to their needs, including for COVID-19 vaccine rollout, and competent to
deliver good standards of care to ensure safe immunization practices (60). Furthermore, it is
critical to integrate the current workforce needs for urgent COVID-19 vaccine rollout into the
broader health system.
The key stakeholders and health facilities that provide COVID-19 vaccination services for these
populations should be identified and mapped, and assessed for readiness, vaccination capacity,
policy and protocols. The WHO guidance for COVID-19 vaccine can be used to guide this
development process (16).
Surveillance systems and routine immunization data collection systems should be strengthened
or designed to capture data on COVID-19 epidemiology, testing, treatment and vaccination
uptake in all refugees, migrant, asylum seeker and IDP populations (57). This would be greatly
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•

facilitated if information on vaccine uptake was disaggregated so that national authorities can
see the extent to which different groups are being reached (61).
In the context of mobility and international travel, WHO recommends that Member States do
not require proof of COVID-19 vaccination as a mandatory condition for entry to or exit from a
country given the limited (although growing) evidence about the performance of vaccines in
reducing transmission and persistent inequities in global vaccine supply. 2 It also advises
countries to reduce the current financial burden on international travellers for measures that they
must comply with for the protection of public health (testing, isolation/quarantine and
vaccination) (35). Banning entry precludes access to territory and asylum procedures for people
in need of international protection.

Promoting vaccine uptake and addressing vaccine hesitancy
•

•

•

•

•

•

The demand for vaccines for refugees and migrants needs to be carefully synchronized with
supply availability to ensure that doses are not wasted. Demand should not outstrip a country's
ability to administer/deliver the doses it receives and allocates to avoid eroding public trust (33).
Promoting refugee- and migrant-friendly health systems and implementing policies affirming
and protecting human rights and dignity can help to address vaccine hesitancy. Specific
strategies to improve trust and counter misinformation and the infodemic of fake news that
makes it hard for people to find trustworthy sources and reliable guidance when they need it (8)
are also required.
Assessments of barriers to accessing COVID-19 vaccine should be conducted and cover vaccine
perceptions, potential conflicts due to xenophobia and risks of exclusion. Enablers for effective
communication among refugee, migrant and local communities should also be assessed (33).
Assessments should be conducted with the full involvement of refugee and migrant populations.
Innovative tailored and targeted approaches will be needed to reach and engage with refugee
and migrant communities that are unconnected with mainstream services or have specific risk
factors for under-immunization. Mobile vaccination clinics, pop-up clinics in nonclinical
venues, combined health-care services and mass vaccination campaigns may be considered (16).
Authorities at national, regional and local levels should work closely and proactively with
community-based organizations, migrants' rights organizations and community leaders to
identify challenges and devise concrete strategies to address them.
Firewalls should be put in place to shield migrants in irregular situations from the possible
transfer of their personal data to immigration authorities and the risk of facing immigration
enforcement measures when they attempt to access health-care services, including COVID-19
immunization (59). Alternative and flexible registration options should include safeguards to
ensure that information provided to health-care providers during vaccination is not shared with
immigration authorities or used for enforcement. Effective outreach campaigns are needed to
highlight the removing of immigration checks for migrants in irregular situations, with specific
information on how and where they can access vaccines.
Research is needed to understand the reasons for under-immunization in these populations and
communities, including overcoming individual, social and structural barriers to vaccination, as
well as identifying mechanisms for innovative interventions. Engagement with refugees and
migrants, particularly those in vulnerable or irregular situations, is essential to understand the
realities these communities experience (33,38).

The WHO Director General issued this recommendation to all States Parties to the International Health Regulations (2005) on two occasions,
after the sixth and seventh meetings of the IHR Emergency Committee on COVID-19 (15 January and 19 April 2021, respectively).

2
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Engaging communities in COVID-19 vaccination planning and implementation
and enhancing effective communication to build trust and counter
misinformation
•

•

•

•

Engaging and communicating with refugees and migrants requires participatory approaches in
order to develop inclusive and acceptable policies and practices for increasing COVID-19
vaccine uptake. These need to be community centred, co-designed with at-risk refugee and
migrant communities and distributed through local communication channels using community
leaders and peer support (61).
In humanitarian settings, it is important to enter systematically into new partnerships with
humanitarian actors who are already active in missed or under-vaccinated communities and
have experience implementing vaccination campaigns (62).
Clear communication strategies are needed to address both host and refugee and migrant
communities to explain the selection of priority groups and why certain groups are not receiving
the vaccine. A specific focus is also needed on countering misinformation on COVID-19
vaccines and promoting uptake (63).
Culturally and linguistically appropriate, accurate, timely and user-friendly information should
be provided, including key messages in accessible formats (including mobile or social media
systems) at the health facilities providing COVID-19 vaccination for refugees and migrants
(59). Local leaders, such as mayors, and community and religious leaders can play a strong role
in the development and relaying of messages.

Develop innovative approaches and vaccination strategies for refugees and
migrants living in hard-to-reach areas
•

•

•

National vaccination policies need to adopt innovative measures for hard-to-reach populations
living in conflict or in secured areas, and where centralized vaccination policies and
implementation strategies may face additional barriers to building trust. Direct engagement of
private sector actors, trust mediators, humanitarian actors, national and civil society
organizations and community leaders should be considered (63).
Civil society organizations or other emergency vaccination services may provide immunization
services and a paper-based vaccine certificate and ask people if they would like to be registered
in national registries. Policy-makers and institutions may agree to include an anonymous code
for those who wish not to be registered (63).
It is critical to strengthen and expand the capacity of health systems, including primary healthcare providers and provide health literacy education programmes regarding health services to
refugees and migrants. Training to increase awareness among health-care providers prior to
vaccination efforts could include simulation exercises. Distribution strategies are needed for
hard-to-reach populations and immunization information systems to monitor vaccination
coverage. National immunization programmes should be resilient to humanitarian or health
crises. Lessons learned from previous campaign and immunization outreach efforts used to
reach such populations should be considered in developing strategies.
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